These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2795004)

  • 1. Role of ribonuclease and ribonuclease inhibitor activities in Alzheimer's disease.
    Jones LM; Knowler JT
    J Neurochem; 1989 Nov; 53(5):1341-4. PubMed ID: 2795004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribonuclease activities and distribution in Alzheimer's and control brains.
    Maschhoff K; White CL; Jennings LW; Morrison-Bogorad MR
    J Neurochem; 1989 Apr; 52(4):1071-8. PubMed ID: 2926389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease brain: alterations in RNA levels and in a ribonuclease-inhibitor complex.
    Sajdel-Sulkowska EM; Marotta CA
    Science; 1984 Aug; 225(4665):947-9. PubMed ID: 6206567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain messenger RNA levels and ribonuclease activity in Alzheimer's disease.
    Morrison MR; Pardue S; Maschoff K; Griffin WS; White CL; Gilbert J; Roses A
    Biochem Soc Trans; 1987 Feb; 15(1):133-4. PubMed ID: 3556737
    [No Abstract]   [Full Text] [Related]  

  • 5. Adenylyl cyclase activity in postmortem human brain: evidence of altered G protein mediation in Alzheimer's disease.
    Cowburn RF; O'Neill C; Ravid R; Alafuzoff I; Winblad B; Fowler CJ
    J Neurochem; 1992 Apr; 58(4):1409-19. PubMed ID: 1548475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in the interaction between iron regulatory proteins and their iron responsive element in normal and Alzheimer's diseased brains.
    Piñero DJ; Hu J; Connor JR
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):761-76. PubMed ID: 10875438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles, and patterns of selective vulnerability.
    Wright CI; Geula C; Mesulam MM
    Ann Neurol; 1993 Sep; 34(3):373-84. PubMed ID: 8363355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme in Alzheimer's disease increased activity in caudate nucleus and cortical areas.
    Arregui A; Perry EK; Rossor M; Tomlinson BE
    J Neurochem; 1982 May; 38(5):1490-2. PubMed ID: 6278093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain.
    Sheu KF; Kim YT; Blass JP; Weksler ME
    Ann Neurol; 1985 May; 17(5):444-9. PubMed ID: 4004169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenylethanolamine N-methyltransferase activity is decreased in Alzheimer's disease brains.
    Burke WJ; Chung HD; Nakra BR; Grossberg GT; Joh TH
    Ann Neurol; 1987 Aug; 22(2):278-80. PubMed ID: 3662456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease.
    Kalaria RN; Sromek SM; Grahovac I; Harik SI
    Brain Res; 1992 Jul; 585(1-2):87-93. PubMed ID: 1511337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress.
    Martins RN; Harper CG; Stokes GB; Masters CL
    J Neurochem; 1986 Apr; 46(4):1042-5. PubMed ID: 3950618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of metabolic enzyme transcripts in Alzheimer's disease.
    Brooks WM; Lynch PJ; Ingle CC; Hatton A; Emson PC; Faull RL; Starkey MP
    Brain Res; 2007 Jan; 1127(1):127-35. PubMed ID: 17109828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum interrupts the formation of alkaline-ribonuclease-inhibitor complex from bovine brain.
    Cho SW; Kim GY
    Eur J Biochem; 1991 Nov; 202(1):107-11. PubMed ID: 1935968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired G-protein-stimulated adenylyl cyclase activity in Alzheimer's disease brain is not accompanied by reduced cyclic-AMP-dependent protein kinase A activity.
    Bonkale WL; Fastbom J; Wiehager B; Ravid R; Winblad B; Cowburn RF
    Brain Res; 1996 Oct; 737(1-2):155-61. PubMed ID: 8930361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phospholipid-metabolizing enzymes in Alzheimer's disease: increased lysophospholipid acyltransferase activity and decreased phospholipase A2 activity.
    Ross BM; Moszczynska A; Erlich J; Kish SJ
    J Neurochem; 1998 Feb; 70(2):786-93. PubMed ID: 9453575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase activity is increased in Alzheimer's disease brain.
    Johnson GV; Cox TM; Lockhart JP; Zinnerman MD; Miller ML; Powers RE
    Brain Res; 1997 Mar; 751(2):323-9. PubMed ID: 9099822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residues 287-301 of human ribonuclease inhibitor do not affect ribonuclease activity and inhibitor binding; a reply.
    Fominaya J; Neumann U; Hofsteenge J
    Biochim Biophys Acta; 1993 Nov; 1203(1):168-70. PubMed ID: 8218387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.